Allergan Inc. Accused Of Paying Kickbacks To Spur Eye Drug Sales

Published: Dec 19, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A False Claims Act lawsuit unsealed this week accuses aesthetics devices maker Allergan of handing out kickbacks to get doctors to prescribe the company's eye drugs. A pair of Philadelphia ophthalmologists accused medtech company Allergan (NYSE:AGN) of offering doctors illegal kickbacks in exchange for prescriptions of the Allergan's eye drugs. The docs claimed that Allergan explicitly offered to trade prescriptions for consulting services that promised to boost clinic profits and help target patients with "dry eye," according to Corporate Crime Reporter.

Help employers find you! Check out all the jobs and post your resume.

Back to news